Annual CFF:
-$60.60M+$79.58M(+56.77%)Summary
- As of today, COLL annual cash from financing is -$60.60 million, with the most recent change of +$79.58 million (+56.77%) on December 31, 2024.
- During the last 3 years, COLL annual cash from financing has risen by +$28.70 million (+32.14%).
- COLL annual cash from financing is now -113.88% below its all-time high of $436.72 million, reached on December 31, 2022.
Performance
COLL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$48.37M-$23.13M(-91.67%)Summary
- As of today, COLL quarterly cash from financing is -$48.37 million, with the most recent change of -$23.13 million (-91.67%) on June 1, 2025.
- Over the past year, COLL quarterly cash from financing has increased by +$65.84 million (+57.65%).
- COLL quarterly cash from financing is now -109.34% below its all-time high of $517.76 million, reached on March 31, 2022.
Performance
COLL Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$34.15M+$65.84M(+207.74%)Summary
- As of today, COLL TTM cash from financing is $34.15 million, with the most recent change of +$65.84 million (+207.74%) on June 1, 2025.
- Over the past year, COLL TTM cash from financing has increased by +$365.74 million (+110.30%).
- COLL TTM cash from financing is now -92.24% below its all-time high of $439.93 million, reached on March 31, 2022.
Performance
COLL TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
COLL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +56.8% | +57.6% | +110.3% |
| 3Y3 Years | +32.1% | -101.8% | -92.0% |
| 5Y5 Years | -3069.3% | -296.1% | -88.6% |
COLL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -113.9% | +56.8% | -132.5% | +57.6% | -92.2% | +110.3% |
| 5Y | 5-Year | -113.9% | +56.8% | -109.3% | +57.6% | -92.2% | +110.3% |
| All-Time | All-Time | -113.9% | +56.8% | -109.3% | +57.6% | -92.2% | +110.3% |
COLL Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$48.37M(-91.7%) | $34.15M(+207.7%) |
| Mar 2025 | - | -$25.24M(+38.9%) | -$31.69M(+47.7%) |
| Dec 2024 | -$60.60M(+56.8%) | -$41.28M(-127.7%) | -$60.60M(+30.5%) |
| Sep 2024 | - | $149.03M(+230.5%) | -$87.15M(+73.7%) |
| Jun 2024 | - | -$114.21M(-110.9%) | -$331.59M(-26.3%) |
| Mar 2024 | - | -$54.15M(+20.2%) | -$262.62M(-87.3%) |
| Dec 2023 | -$140.18M(-132.1%) | -$67.83M(+28.9%) | -$140.18M(-42.8%) |
| Sep 2023 | - | -$95.41M(-110.9%) | -$98.17M(-188.6%) |
| Jun 2023 | - | -$45.24M(-166.2%) | -$34.01M(-166.9%) |
| Mar 2023 | - | $68.30M(+364.5%) | -$12.74M(-102.9%) |
| Dec 2022 | $436.72M(+589.0%) | -$25.82M(+17.4%) | $436.72M(+4.0%) |
| Sep 2022 | - | -$31.25M(-30.4%) | $420.05M(-1.1%) |
| Jun 2022 | - | -$23.97M(-104.6%) | $424.79M(-3.4%) |
| Mar 2022 | - | $517.76M(+1318.3%) | $439.93M(+592.6%) |
| Dec 2021 | -$89.30M(-131.2%) | -$42.50M(-60.3%) | -$89.30M(-50.8%) |
| Sep 2021 | - | -$26.51M(-200.2%) | -$59.21M(-32.4%) |
| Jun 2021 | - | -$8.83M(+23.0%) | -$44.73M(+7.0%) |
| Mar 2021 | - | -$11.47M(+7.5%) | -$48.11M(-116.8%) |
| Dec 2020 | $286.47M(>+9900.0%) | -$12.40M(-3.1%) | $286.47M(-4.6%) |
| Sep 2020 | - | -$12.03M(+1.5%) | $300.29M(-4.0%) |
| Jun 2020 | - | -$12.21M(-103.8%) | $312.73M(-3.8%) |
| Mar 2020 | - | $323.12M(>+9900.0%) | $324.99M(>+9900.0%) |
| Dec 2019 | $2.04M | $1.41M(+247.4%) | $2.04M(+106.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $407.00K(+698.0%) | -$33.05M(+50.3%) |
| Jun 2019 | - | $51.00K(-69.8%) | -$66.53M(+43.0%) |
| Mar 2019 | - | $169.00K(+100.5%) | -$116.64M(+0.5%) |
| Dec 2018 | -$117.20M(-450.1%) | -$33.67M(-1.8%) | -$117.20M(-98.7%) |
| Sep 2018 | - | -$33.07M(+33.9%) | -$58.97M(-255.5%) |
| Jun 2018 | - | -$50.06M(>-9900.0%) | -$16.59M(-150.2%) |
| Mar 2018 | - | -$388.00K(-101.6%) | $33.04M(-1.3%) |
| Dec 2017 | $33.48M(-75.3%) | $24.55M(+163.8%) | $33.48M(-64.7%) |
| Sep 2017 | - | $9.31M(+2249.9%) | $94.75M(+11.1%) |
| Jun 2017 | - | -$433.00K(-966.0%) | $85.25M(+0.2%) |
| Mar 2017 | - | $50.00K(-99.9%) | $85.06M(-37.3%) |
| Dec 2016 | $135.56M(+16.9%) | $85.83M(>+9900.0%) | $135.56M(+176.1%) |
| Sep 2016 | - | -$194.00K(+68.8%) | $49.10M(+0.1%) |
| Jun 2016 | - | -$622.00K(-101.2%) | $49.02M(-59.7%) |
| Mar 2016 | - | $50.55M(+8035.5%) | $121.50M(+4.8%) |
| Dec 2015 | $115.99M(+863.5%) | -$637.00K(-140.4%) | $115.99M(-4.7%) |
| Sep 2015 | - | -$265.00K(-100.4%) | $121.66M(-4.9%) |
| Jun 2015 | - | $71.86M(+59.6%) | $127.92M(+128.2%) |
| Mar 2015 | - | $45.04M(+795.2%) | $56.04M(+365.6%) |
| Dec 2014 | $12.04M(-2.5%) | $5.03M(-16.1%) | $12.04M(+71.8%) |
| Sep 2014 | - | $5.99M(>+9900.0%) | $7.01M(+591.0%) |
| Jun 2014 | - | -$17.00K(-101.6%) | $1.01M(-1.6%) |
| Mar 2014 | - | $1.03M | $1.03M |
| Dec 2013 | $12.35M | - | - |
FAQ
- What is Collegium Pharmaceutical, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. annual cash from financing year-on-year change?
- What is Collegium Pharmaceutical, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. quarterly cash from financing year-on-year change?
- What is Collegium Pharmaceutical, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. TTM cash from financing year-on-year change?
What is Collegium Pharmaceutical, Inc. annual cash from financing?
The current annual cash from financing of COLL is -$60.60M
What is the all-time high annual cash from financing for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high annual cash from financing is $436.72M
What is Collegium Pharmaceutical, Inc. annual cash from financing year-on-year change?
Over the past year, COLL annual cash from financing has changed by +$79.58M (+56.77%)
What is Collegium Pharmaceutical, Inc. quarterly cash from financing?
The current quarterly cash from financing of COLL is -$48.37M
What is the all-time high quarterly cash from financing for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high quarterly cash from financing is $517.76M
What is Collegium Pharmaceutical, Inc. quarterly cash from financing year-on-year change?
Over the past year, COLL quarterly cash from financing has changed by +$65.84M (+57.65%)
What is Collegium Pharmaceutical, Inc. TTM cash from financing?
The current TTM cash from financing of COLL is $34.15M
What is the all-time high TTM cash from financing for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high TTM cash from financing is $439.93M
What is Collegium Pharmaceutical, Inc. TTM cash from financing year-on-year change?
Over the past year, COLL TTM cash from financing has changed by +$365.74M (+110.30%)